VACCINE MANIA: HISTORY OF THE HPV VACCINE and GARDASIL

INTRODUCTION: This opening article was written by Carol Boyce, a friend of mine, back in 2007. What has happened since?

Gardasil fantasies

Merck shareholders, still stinging from the financial effects of the company’s Vioxx debacle, were granted a reprieve with the announcement of the company’s new HPV vaccine to “prevent” 70% of cervical-cancer deaths. Fast-tracked by the FDA and hailed as the biggest public-health breakthrough in years, this genetically engineered vaccine had 1,637 adverse reaction reports filed in its first year of use, (June 2007). These include instances of life-threatening Guillian–Barré syndrome, syncopal episodes and seizures, and three deaths. (1) As of June 2011, there have been a total of 18,727 reports of adverse events following Gardasil® vaccination, including 68 deaths. (2) (Editor’s note: At the last count there have been 102 deaths and over 22,000 notified side effects of the vaccine. However, as reported in the book Vaccine Epidemic, reviewed in this journal, only between 1-10 and up to 1-100 of side effects are reported or acknowledged.)

Merck admits that:

• length of conferred immunity is not yet known, but the estimate is three to five

years;

• cervical lesions may be higher in vaccinated women already HPV positive; and

since not all women will be protected (even ignoring the potential for mutation of

the target viruses), every woman will still need regular cervical screening. (3)

Despite these admissions, twenty U.S. states moved forward with legislation for mandatory vaccination of children and college students (trials on males and older women are under way); The Lancet called for the European Union to lead by example and enforce vaccination of adolescents; Australia began a free national Gardasil program and the WHO recommended that developing countries get on board. Eighty six countries have so far approved use of the vaccine.

Given that cervical screening programs will still be required and have already proven both their effectiveness and their cost effectiveness — already cutting the rate of cervical cancer by 70% since screening programs began — the proposals for mass use of Gardasil have yet to be justified. The global mortality rate for this cancer is 250,000 per annum, 80% of which is in the developing world. The U.S. mortality rate is low (3,700 per annum) and was already falling rapidly before Gardasil became available. The Wall Street Journal confirmed that Merck was “desperate” for a “revenue stream” and that vaccination across the U.S. would make Gardasil an “automatic blockbuster”. (4) At US$360 a person for the initial course and boosters at US$120 every three to five years thereafter per person who is either sexually active or legally compelled to have it, the vaccine offered the possibility of solving Merck’s financial challenge in just one move.

In June 2006 Gardasil was licensed for use in females, age 9-26 years and in Oct 2009 for males age 9-26 years. In the U.S. alone, the first ten years of blanket coverage for Merck’s ultimate target population of 9-to 26-year-olds would cost more than US$85 billion, without reducing the cost of the current screening programs. Gardasil sales went off like a rocket with over $1.1 billion grossed within the first nine months of release, but adverse publicity about vaccine related deaths and the challenge of an expensive three dose vaccine has seen sales fall, and Merck share prices along with them. (5) Nonetheless, Gardasil is still Merck’s best seller and expected to pull in $1 billion a year.

Mandatory mass vaccination for a non-epidemic disease represents a disturbing departure from accepted medical practice. Since cervical cancer takes 15 to 20 years to develop, the vast majority of cervical cancers are detected via established screening programs, and cervical-cancer mortality rates are rapidly falling already. Therefore, the predicted reduction in death rate would not even begin to take effect for at least 20 years and would not be measurable for decades after that, if ever. Professor Diane Harper, who led two of the HPV vaccine trials, had serious misgivings about promotion of widespread vaccination, describing it as “a great big public-health experiment”. (6)

Marketing at its finest

Merck mounted a vigorous marketing campaign for Gardasil, aimed at young women aged 11–26. Ingeniously marketed as a vaccine to “prevent cervical cancer” they used healthy, hip young women in the television advertising who told us they were “One less” — referring to the predicted reduction in mortality. If we scratch the surface of the proposed state legislation to make the vaccine mandatory, we find a group of legislators called Women in Government, pushing hard for the mandatory HPV vaccination of school children — and funded by Merck. (7)

The European Commission approved sale of the vaccine in Europe. In Paris, a rally of medical professionals and celebrities in the Spring of its release called for the compulsory vaccination of 11- and 12-year-olds. That rally was entirely funded by Sano Pasteur, Merck's European marketing arm.

Gardasil in 2025?

The following article found on the Children’s Health Defense site, updates the research on the impact of Gardasil and other HPV vaccines and the flawed science used by drug companies. It highlights the significant side effects and deaths seen since the vaccines have been released and the fact that, at least in the USA, they have been mandated by law in many states, questioning once again, the political and financial power of Big Pharma to impose public health policy in the form of mandated vaccines, a gross example of the abuse of power and imposition of health laws as a form of “medical fascism.”

Here is an extract from the article with references on the site to other articles:

Multiple lawsuits allege Merck knew about risks, failed to warn public

Over the last several years, hundreds of plaintiffs who suffered debilitating injuries after taking the Gardasil shot have filed lawsuits against Merck in state and federal court.

Using one of the few legal mechanisms allowing injured people to sue vaccine-makers directly, the lawsuits allege that Merck knew Gardasil carries multiple risks, including ovarian failure and POTS[CB2] ,(Postural Tachycardia Syndrome) but failed to warn the public.

The first case to go to trial in state court in California is on hold. The lawsuits in federal court were combined into a multi-district litigation. In March, a federal judge ruled in Merck’s favor before the trial even got underway, saying the company didn’t have the authority to add warnings to its label. Plaintiffs are appealing the ruling.

Expert reports made public in both trials, however, showed that Merck and regulators cherry-picked data to claim there was no link between Gardasil and POTS. They also showed that the company did not disclose an additional, aluminum-based adjuvant, present in the vaccine.

Another expert report from Danish physician and world-renowned research methodologist, Dr. Peter C. Gøtzsche, concluded that Merck manipulated its data to such an extent that it would be “difficult if not impossible” for any independent scientist — or even government regulators — to accurately assess the vaccine’s harms.

Gardasil is recommended for all boys and girls starting at age 11 and through age 26, although it can be started at age 9, and for some adults ages 27 through 45.

Related articles in The Defender:

· Merck Knew Gardasil Contained Unapproved Ingredient but Didn’t Tell Public

· ‘Indefensible’: Merck Designed Gardasil Trials to Mask HPV Vaccine Harms

· CDC Relied on Cherry-picked Data to Claim No Link Between Merck’s Gardasil Vaccine and POTS

· Plaintiffs Will Appeal Ruling in Merck Gardasil Vaccine Injury Case

· Breaking: Federal Judge Hands Merck Win in Key Gardasil HPV Vaccine Case

· Merck to Face California Jury as ‘Historic’ Gardasil HPV Vaccine Trial Gets Under Way

· Gardasil’s Long Shadow of Autoimmunity Confirmed — Again — by New Study

CONCLUSION: As has been seen with the Covid vaccine, in spite of all the evidence of harm, which is only growing larger, various medical organizations and Big Pharma are still insisting the vaccine works and is safe. HHS head, RFK Jnr is now being sued in the U.S. for removing the Covid vaccine for healthy young people and pregnant women. The HPV vaccine is in the same position. Despite the lack of evidence of its efficacy, the lack of testing with placebo trials over a long period to validate efficacy and safety, and the evidence of harm from the vaccine, government medical bodies and Big Pharma still push the vaccine and ideally mandate it for all young children at age 11 and up. If ever there was an example where the vested interests of Pharma and the complicity of government come together in a conspiracy of collusion, this vaccine is it.

1. FDA adverse effect reports for HPV vaccine. http://www.judicialwatch.org/6299.shtml

2. Centers for Disease Control, Reports of Health Concerns Following HPV Vaccination.

http://www.cdc.gov/vaccinesafety/vaccines/hpv/gardasil.html

3. Kaufman M. FDA approves vaccine that should prevent most cervical cancers.

The Washington Post, 9 June 2006, pg A01

4. Carreyrou J. Moves to vaccinate girls for cervical cancer draw fire.

The Wall Street Journal, 7 Feb 2007 pg D1

5. DuBois, S. What went wrong with Gardasil CNN Money, Sept 7 2010

6. Boseley S. Vaccination campaign funded by drug firm. The Guardian, 26 March 2007

7. Peterson L.A. Merck lobbies states to require vaccine. Concord Monitor online, 31 Jan 2007